Type 2 diabetes Nutritional, Metabolic, Endocrine Diabetes
Conditions
Interventions
1. Cerivastatin and placebo
2. Fenofibrate and placebo
3. Cerivastatin and fenofibrate
4. Placebo
Sponsors
Bayer PLC (UK)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Established type 2 diabetics aged between 40 and 75
Exclusion criteria
Exclusion criteria: Not provided at time of registration
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Not provided at time of registration | — |
Secondary
| Measure | Time frame |
|---|---|
| Not provided at time of registration | — |
Countries
United Kingdom
Outcome results
None listed